178 related articles for article (PubMed ID: 36326314)
21. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
Jin W; Fei X; Wang X; Chen F; Song Y
J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
[TBL] [Abstract][Full Text] [Related]
22. Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs.
Erdmann K; Kaulke K; Thomae C; Huebner D; Sergon M; Froehner M; Wirth MP; Fuessel S
BMC Cancer; 2014 Feb; 14():82. PubMed ID: 24517338
[TBL] [Abstract][Full Text] [Related]
23. Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer.
Khan MM; Serajuddin M; Bharadwaj M
Biomarkers; 2023 Mar; 28(2):227-237. PubMed ID: 36644827
[No Abstract] [Full Text] [Related]
24. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
25. Importance of miR-20a expression in prostate cancer tissue.
Pesta M; Klecka J; Kulda V; Topolcan O; Hora M; Eret V; Ludvikova M; Babjuk M; Novak K; Stolz J; Holubec L
Anticancer Res; 2010 Sep; 30(9):3579-83. PubMed ID: 20944140
[TBL] [Abstract][Full Text] [Related]
26. miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia.
Gunawan RR; Astuti I; Danarto HR
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1095-1099. PubMed ID: 36974566
[TBL] [Abstract][Full Text] [Related]
27. Construction of a Diagnostic Model for Distinguishing Benign or Malignant Bone Cancer by Mining miRNA Expression Data.
Zhang Y; Hu J; Li T; Hao S; Wu X
Biochem Genet; 2023 Feb; 61(1):299-315. PubMed ID: 35861903
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
29. MiR-145 affected the circular RNA expression in prostate cancer LNCaP cells.
He JH; Han ZP; Zhou JB; Chen WM; Lv YB; He ML; Li YG
J Cell Biochem; 2018 Nov; 119(11):9168-9177. PubMed ID: 30136305
[TBL] [Abstract][Full Text] [Related]
30. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population.
Zhang N; Wang J; Zhang S; Wu H; Li Z; Hu M
Biomarkers; 2023 Jun; 28(4):372-378. PubMed ID: 37185057
[TBL] [Abstract][Full Text] [Related]
32. Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress.
Aczél T; Benczik B; Ágg B; Körtési T; Urbán P; Bauer W; Gyenesei A; Tuka B; Tajti J; Ferdinandy P; Vécsei L; Bölcskei K; Kun J; Helyes Z
J Headache Pain; 2022 Sep; 23(1):113. PubMed ID: 36050647
[TBL] [Abstract][Full Text] [Related]
33. Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.
Paziewska A; Mikula M; Dabrowska M; Kulecka M; Goryca K; Antoniewicz A; Dobruch J; Borowka A; Rutkowski P; Ostrowski J
Prostate; 2018 Feb; 78(3):178-185. PubMed ID: 29226351
[TBL] [Abstract][Full Text] [Related]
34. Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.
Ambrozkiewicz F; Karczmarski J; Kulecka M; Paziewska A; Cybulska M; Szymanski M; Dobruch J; Antoniewicz A; Mikula M; Ostrowski J
Biomed Res Int; 2020; 2020():9086829. PubMed ID: 32462034
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract][Full Text] [Related]
36. Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer.
Dong L; Hu C; Ma Z; Huang Y; Shelley G; Kuczler MD; Kim CJ; Witwer KW; Keller ET; Amend SR; Xue W; Pienta KJ
Med Oncol; 2024 Jun; 41(7):169. PubMed ID: 38839666
[TBL] [Abstract][Full Text] [Related]
37. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
38. [miRNA Expression Profile in Ileocecal Adenocarcinoma Cells Infected with Cryptosporidium].
Ulusan Bağcı Ö; Caner A
Mikrobiyol Bul; 2022 Jul; 56(3):449-465. PubMed ID: 35960237
[TBL] [Abstract][Full Text] [Related]
39. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.
Feng F; Wu J; Gao Z; Yu S; Cui Y
Medicine (Baltimore); 2017 Jan; 96(1):e5679. PubMed ID: 28072703
[TBL] [Abstract][Full Text] [Related]
40. microRNA Expression Profiling in Young Prostate Cancer Patients.
Valera VA; Parra-Medina R; Walter BA; Pinto P; Merino MJ
J Cancer; 2020; 11(14):4106-4114. PubMed ID: 32368293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
